Dr. Reddy's Laboratories Ltd ADRDRREDDY
Price$12.25Intrinsic value$13.299% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.8B+13.8% YoYTTM through 31 Mar 2025
Net Income $671M+0.4% YoYTTM through 31 Mar 2025
Free Cash Flow $223MTTM through 31 Mar 2025

Margins

Current
Gross Margin52.8%
Operating Margin15.0%
Net Margin17.6%

Returns

11.2%ROE
11.6%ROA
15.8%ROIC

Balance Sheet Health

Debt / Equity0.02x
Current Ratio1.92x
Net Debt-$32.7Bnet cash position
Cash & Equivalents$172M

Quality Metrics

Piotroski F-Score2 / 9
FCF Margin5.9%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $325.5B
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $67.78

Dividend

$0.09Per share, FY20250.72%Yield+6.6%5-yr growth

Capital Allocation

Capex Intensity8.4%
Financials converted at 85.4681 from INR.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.